AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Bosi, A Laszlo, D Labopin, M Reffeirs, J Michallet, M Gluckman, E Alessandrino, PE Locatelli, F Vernant, JP Sierra, J Jouet, JP Frassoni, F
Citation: A. Bosi et al., Second allogeneic bone marrow transplantation in acute leukemia: Results of a survey by the European Cooperative Group for Blood and Marrow Transplantation, J CL ONCOL, 19(16), 2001, pp. 3675-3684

Authors: Reiffers, J Labopin, M Sanz, M Korbling, M Blaise, D De la Rubia, J Gorin, NC
Citation: J. Reiffers et al., Autologous blood cell vs marrow transplantation for acute myeloid leukemiain complete remission: an EBMT retrospective analysis, BONE MAR TR, 25(11), 2000, pp. 1115-1119

Authors: Ringden, O Labopin, M Gorin, NC Meloni, G Blaise, D Reiffers, J Carlson, K Fouillard, L Frassoni, F
Citation: O. Ringden et al., The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed, BONE MAR TR, 25(10), 2000, pp. 1053-1058

Authors: Frassoni, F Labopin, M Powles, R Mary, JY Arcese, W Bacigalupo, A Bunjes, D Gluckman, E Ruutu, T Schaefer, UW Sierra, J Vernant, JP Willemze, R de Witte, T Gorin, NC
Citation: F. Frassoni et al., Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia, LANCET, 355(9213), 2000, pp. 1393-1398

Authors: Ringden, O Labopin, M Gorin, NC Schmitz, N Schaefer, UW Prentice, HG Bergmann, L Jouet, JP Mandelli, F Blaise, D Fouillard, L Frassoni, F
Citation: O. Ringden et al., Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?, BR J HAEM, 111(4), 2000, pp. 1130-1137

Authors: Gorin, NC Labopin, M Pichard, P Sierra, J Fiere, D Rio, B Meloni, G Sanz, MA Iriondo, A Fouillard, L Frassoni, F
Citation: Nc. Gorin et al., Feasibility and recent improvement of autologous stem cell transplantationfor acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells, BR J HAEM, 110(4), 2000, pp. 887-893

Authors: Cahn, JY Labopin, M Sierra, J Blaise, D Reiffers, J Ferrant, A Bergmann, L Visani, G Cornelissen, J De Witte, T Bosi, A Frassoni, F Gorin, NC
Citation: Jy. Cahn et al., No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission, BR J HAEM, 110(2), 2000, pp. 308-314

Authors: Gorin, NC Labopin, M Laporte, JP Douay, L Lopez, M Lesage, S Fouillard, L Isnard, F Jouet, JP Bellal, N Perot, C Van Den Akker, J Bauters, F Najman, A
Citation: Nc. Gorin et al., Importance of marrow dose on posttransplant outcome in acute leukemia: Models derived from patients autografted with mafosfamide-purged marrow at a single institution, EXP HEMATOL, 27(12), 1999, pp. 1822-1830

Authors: Ringden, O Labopin, M Frassoni, F Sanz, GF Demeocq, F Prentice, HG Cahn, JY Barbui, T Meloni, G Schaefer, UW Reiffers, J Gorin, NC
Citation: O. Ringden et al., Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft, BONE MAR TR, 24(4), 1999, pp. 389-396

Authors: Gorin, NC Labopin, M
Citation: Nc. Gorin et M. Labopin, Treatment of acute myeloid leukemia, N ENG J MED, 340(18), 1999, pp. 1437-1437
Risultati: 1-10 |